GV’s Philippakis joins gene editing letter to HHS Secretary Azar


VCJ Venture
Photo concept of genetic manipulation and DNA modification courtesy of vchal/iStock/Getty Images.
GV Venture Partner Anthony Philippakis has joined a letter to U.S. Health and Human Services Secretary Alex Azar calling for a global moratorium on germline gene editing. The letter was submitted on April 24 and is signed by more than ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.